Abstract
Radiation therapy is commonly used to treat nonmelanoma skin cancer (NMSC) and melanoma. Historically there have been a wide range of doses utilized for NMSC, depending on tumor location, age/performance status of patients, desired cosmetic outcome, and presence of high-risk features such as PNI. Melanoma has been thought of as a more radioresistant tumor; however, this thinking is changing based on newer data. This chapter summarizes the use of hypofractionated RT for both NMSC and melanoma in the definitive setting.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ballo MT, Burmeister BH. Malignant melanoma. Clinical radiation oncology. 4th ed. Philadelphia: Saunders/Elsevier; 2016. p. 777–87.
Screening and early detection of melanoma. Accessed 25 July 2016.
Radiation therapy in the management of melanoma. Accessed 25 July 2016.
Veness MJ, Howle J. Cutaneous carcinoma. Clinical radiation oncology. 4th ed. Philadelphia: Saunders/Elsevier; 2016. p. 763–76.
Million RR, Cassisi NJ. Management of head and neck cancer: a multidisciplinary approach. 2nd ed. Philadelphia: Lippincott; 1994.
Ang KK, Byers RM, Peters LJ, et al. Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Preliminary results. Arch Otolaryngol Head Neck Surg. 1990;116:169–72.
Chang DT, Amdur RJ, Morris CG, Mendenhall WM. Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation. Int J Radiat Oncol Biol Phys. 2006;66:1051–5.
Ballo MT, Ross MI, Cormier JN, et al. Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys. 2006;64:106–13.
Burmeister BH, Henderson MA, Ainslie J, et al. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncol. 2012;13:589–97.
Burmeister BH, Mark Smithers B, Burmeister E, et al. A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06. Radiother Oncol. 2006;81:136–42.
Benedict SH, Yenice KM, Followill D, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010;37:4078–101.
Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76:S10–9.
van Hezewijk M, Creutzberg CL, Putter H, et al. Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: analysis of 434 cases. Radiother Oncol. 2010;95:245–9.
Abbatucci JS, Boulier N, Laforge T, Lozier JC. Radiation therapy of skin carcinomas: results of a hypofractionated irradiation schedule in 675 cases followed more than 2 years. Radiother Oncol. 1989;14:113–9.
Sause WT, Cooper JS, Rush S, et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys. 1991;20:429–32.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Judy, G.D., Chera, B.S. (2018). Skin (Melanoma and Nonmelanoma Skin Cancers). In: Kaidar-Person, O., Chen, R. (eds) Hypofractionated and Stereotactic Radiation Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-92802-9_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-92802-9_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92800-5
Online ISBN: 978-3-319-92802-9
eBook Packages: MedicineMedicine (R0)